BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35293069)

  • 1. Characteristics, goal-oriented treatments and survival of pulmonary arterial hypertension in China: Insights from a national multicentre prospective registry.
    Quan R; Zhang G; Yu Z; Zhang C; Yang Z; Tian H; Yang Y; Wu W; Chen Y; Liu Y; Zhu X; Li S; Shen J; Zheng Z; Zhu X; Wang G; Wang Q; Zhou D; Ji Y; Yang T; Li W; Chen X; Qian Y; Lin Y; Gu Q; Xiong C; Shan G; He J
    Respirology; 2022 Jul; 27(7):517-528. PubMed ID: 35293069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics, treatments and survival of pulmonary arterial hypertension associated with congenital heart disease in China: Insights from a national multicenter prospective registry.
    Xie F; Quan R; Zhang G; Tian H; Chen Y; Yu Z; Zhang C; Liu Y; Zhu X; Wu W; Zhu X; Yang Z; Gu Q; Xiong C; Han H; Cheng Y; He J; Wu Y
    J Heart Lung Transplant; 2023 Jul; 42(7):974-984. PubMed ID: 37002152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics, Long-term Survival, and Risk Assessment of Pediatric Pulmonary Arterial Hypertension in China: Insights From a National Multicenter Prospective Registry.
    Qian Y; Quan R; Chen X; Gu Q; Xiong C; Han H; Zhang G; Chen Y; Yu Z; Tian H; Liu Y; Zhu X; Li S; Zhang C; He J
    Chest; 2023 Jun; 163(6):1531-1542. PubMed ID: 36470418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 5. 10-year survival of pulmonary arterial hypertension associated with connective tissue disease: insights from a multicentre PAH registry.
    Chen X; Quan R; Qian Y; Yang Z; Yu Z; Zhang C; Yang Y; Zhang G; Shen J; Wang Q; Gu Q; Xiong C; Jing X; Han H; He J
    Rheumatology (Oxford); 2023 Nov; 62(11):3555-3564. PubMed ID: 36912696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension.
    Chung WJ; Park YB; Jeon CH; Jung JW; Ko KP; Choi SJ; Seo HS; Lee JS; Jung HO;
    J Korean Med Sci; 2015 Oct; 30(10):1429-38. PubMed ID: 26425039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital heart disease with pulmonary artery hypertension in an Asian cohort-initial report from TACHYON (TAiwan congenital heart disease associated with pulmonarY arterial hypertension) registry.
    Chiu SN; Weng KP; Lin MC; Wang JN; Hwang BT; Dai ZK; Lin SM; Chang JS; Lin IC; Wu MH; Lu CW; Lin MT; Chen CA; Hua YC; Wu JM; Wang JK;
    Int J Cardiol; 2020 Oct; 317():49-55. PubMed ID: 32522677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary arterial hypertension in a multi-ethnic Asian population: Characteristics, survival and mortality predictors from a 14-year follow-up study.
    Lim Y; Low TT; Chan SP; Teo TW; Jang JJ; Yip N; Kuntjoro I; Tay EL; Yip JW
    Respirology; 2019 Feb; 24(2):162-170. PubMed ID: 30180305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term impact of add-on sequential triple combination therapy in pulmonary arterial hypertension: real world experience.
    Deshwal H; Weinstein T; Salyer R; Thompson J; Cefali F; Fenton R; Bondarsky E; Sulica R
    Ther Adv Respir Dis; 2023; 17():17534666231199693. PubMed ID: 37795626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry.
    Chang KY; Duval S; Badesch DB; Bull TM; Chakinala MM; De Marco T; Frantz RP; Hemnes A; Mathai SC; Rosenzweig EB; Ryan JJ; Thenappan T;
    J Am Heart Assoc; 2022 May; 11(9):e024969. PubMed ID: 35475351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guideline implementation and early risk assessment in pulmonary arterial hypertension associated with congenital heart disease: A retrospective cohort study.
    Deng X; Jin B; Li S; Li Y; Zhou H; Wu Y; Yan M; Hu Y; Qiu Q; Zhang G; Zheng X
    Clin Respir J; 2019 Nov; 13(11):693-699. PubMed ID: 31419027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital heart disease-associated pulmonary arterial hypertension: preliminary results from a novel registry.
    Rose ML; Strange G; King I; Arnup S; Vidmar S; O'Donnell C; Kermeen F; Grigg L; Weintraub RG; Celermajer DS
    Intern Med J; 2012 Aug; 42(8):874-9. PubMed ID: 22212153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension and congenital heart disease: An insight from the REHAP National Registry.
    Alonso-Gonzalez R; Lopez-Guarch CJ; Subirana-Domenech MT; Ruíz JMO; González IO; Cubero JS; Del Cerro MJ; Salvador ML; Subira LD; Gallego P; Escribano-Subias P;
    Int J Cardiol; 2015 Apr; 184():717-723. PubMed ID: 25781723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical characteristics of 195 Chinese patients with WHO Class I pulmonary hypertension].
    Zhang G; Shang X; Deng X; Zhou H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Dec; 42(12):1001-5. PubMed ID: 25623345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry.
    Chazova IE; Arkhipova OA; Martynyuk TV
    Ter Arkh; 2019 Mar; 91(1):24-31. PubMed ID: 31090367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Humbert M; Farber HW; Ghofrani HA; Benza RL; Busse D; Meier C; Hoeper MM
    Eur Respir J; 2019 Jun; 53(6):. PubMed ID: 30923187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of composite clinical worsening events on outcome of patients with pulmonary arterial hypertension associated with congenital heart disease].
    Xu ZY; Zhang HS; Li QQ; Zhang C; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Mar; 50(3):282-288. PubMed ID: 35340148
    [No Abstract]   [Full Text] [Related]  

  • 18. External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry.
    Boucly A; Weatherald J; Savale L; de Groote P; Cottin V; Prévot G; Chaouat A; Picard F; Horeau-Langlard D; Bourdin A; Jutant EM; Beurnier A; Jevnikar M; Jaïs X; Simonneau G; Montani D; Sitbon O; Humbert M
    Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 34737227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Arterial Hypertension in Indonesia: Current Status and Local Application of International Guidelines.
    Dinarti LK; Anggrahini DW; Lilyasari O; Siswanto BB; Hartopo AB
    Glob Heart; 2021 Apr; 16(1):23. PubMed ID: 34040936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
    Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
    Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.